These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 2424268)

  • 1. Calcium entry blockade and excitation contraction coupling in the cardiovascular system (with an attempt of pharmacological classification).
    Godfraind T
    Acta Pharmacol Toxicol (Copenh); 1986; 58 Suppl 2():5-30. PubMed ID: 2424268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of calcium antagonists.
    Godfraind T
    Am J Cardiol; 1987 Jan; 59(3):11B-23B. PubMed ID: 2433928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. "Calcium antagonists": a class of drugs with a bright future. Part II. Determination of basic pharmacological properties.
    Spedding M; Cavero I
    Life Sci; 1984 Aug; 35(6):575-87. PubMed ID: 6087068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calcium entry blockers and receptor-response coupling.
    Godfraind T
    J Cardiovasc Pharmacol; 1982; 4 Suppl 3():S269-72. PubMed ID: 6184551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of action of Ca++ entry blockers. A comparison of their actions in rat arteries and in human coronary arteries.
    Godfraind T; Miller RC
    Circ Res; 1983 Feb; 52(2 Pt 2):I81-91. PubMed ID: 6831654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potassium channel modulation: a new drug principle for regulation of smooth muscle contractility. Studies on isolated airways and arteries.
    Nielsen-Kudsk JE
    Dan Med Bull; 1996 Dec; 43(5):429-47. PubMed ID: 8960816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Calcium flux regulation in myocardial and vascular smooth muscle.
    Moura AM; Hamon G; Worcel M
    Adv Nephrol Necker Hosp; 1985; 14():173-96. PubMed ID: 2579534
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of calcium entry blockers not connected with calcium channels inhibition.
    Raddino R; Poli E; Ferrari R; Visioli O
    Gen Pharmacol; 1987; 18(4):431-6. PubMed ID: 2440761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcium antagonism: a new approach.
    Nayler WG
    Clin Exp Pharmacol Physiol Suppl; 1982; 6():3-13. PubMed ID: 6288293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium entry blockers and myocardial function.
    Nayler WG; Grinwald P
    Fed Proc; 1981 Dec; 40(14):2855-61. PubMed ID: 6273237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular effects of calcium antagonists. Uses in some cerebrovascular disorders.
    Marin J
    Gen Pharmacol; 1988; 19(3):295-306. PubMed ID: 2458295
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Calcium entry blocking drugs: mechanisms of action, experimental studies and clinical uses.
    McCall D; Walsh RA; Frohlich ED; O'Rourke RA
    Curr Probl Cardiol; 1985 Aug; 10(8):1-80. PubMed ID: 2414067
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged depolarization increases the pharmacological effect of dihydropyridines and their binding affinity for calcium channels of vascular smooth muscle.
    Morel N; Godfraind T
    J Pharmacol Exp Ther; 1987 Nov; 243(2):711-5. PubMed ID: 2824756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NO-1886, a lipoprotein lipase activator, attenuates vascular smooth muscle contraction in rat aorta.
    Nakamura A; Harada N; Takahashi A; Mawatari K; Nakano M; Tsutsumi K; Nakaya Y
    Eur J Pharmacol; 2007 Jan; 554(2-3):183-90. PubMed ID: 17109854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiology of calcium antagonists.
    Sperelakis N
    J Mol Cell Cardiol; 1987 May; 19 Suppl 2():19-47. PubMed ID: 2442399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective modulation by membrane potential of the interaction of some calcium entry blockers with calcium channels in rat mesenteric artery.
    Morel N; Godfraind T
    Br J Pharmacol; 1988 Sep; 95(1):252-8. PubMed ID: 2851351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Calcium entry blockers and vascular smooth muscle heterogeneity.
    Van Nueten JM; Vanhoutte PM
    Fed Proc; 1981 Dec; 40(14):2862-5. PubMed ID: 7308496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of action of calcium entry blockers.
    Godfraind T
    Fed Proc; 1981 Dec; 40(14):2866-71. PubMed ID: 7308497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.